Observational analysis reveals that zoledronic acid reduces fracture risk in elderly patients with osteoporosis, highlighting its potential benefits.
Osteoporosis is one of the most significant medical problems, especially in the context of global population aging. With increased life expectancy, the number of elderly patients with this pathology is growing, which has significant medical and socio-economic consequences. Osteoporosis is characterized by a decrease in bone mineral density, which significantly increases the risk of fractures, especially in older age groups. These pathological changes not only worsen the quality of life of patients, but also lead to increased healthcare costs and increase the social burden.
No takes yet. Share an insight, caveat, or question.
Е. N. Dudinskaya (2025) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: